New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...
The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...
Researchers at UW’s School of Medicine and the Institute for Research in Biomedicine Barcelona may have found an additional ...
Med Center Health has been named a Center of Excellence (COE) by GO2 for Lung Cancer (GO2). An estimated 237,000 Americans ...
StockStory.org on MSN
NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) reported Q3 CY2025 results , with sales up 11.9% year on year ...
"Fueled by advances in NGS and precision medicine, China’s DNA sequencing market sees rapid growth amid strong government support, rising clinical applications, and innovation hubs in Guangdong, ...
NGS continually delivers breakthroughs in genomics, and to do so, it relies on the crucial step of sample preparation. Complex and expensive workflows are significant challenges. At Revvity, we are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback